About CEITEC

• Vision
• Goals
• Strategy
• Core Facilities
  • Nanolithography and Nanofabrication
  • Nanocharacterisation
  • Structural Analysis Laboratory
  • Nanobiotechnology and Biointeractions
  • Single Crystal X-ray Diffraction
  • High-field NMR Spectroscopy
  • Cryo-electron Microscopy and Tomography
  • Proteomics
  • Genomics
  • Molecular and Functional Imaging
• Management of the Centre
• Time Scales
• Financing
• Visualisation
• Project Partners
  • Masaryk University
  • Brno University of Technology
  • Mendel University in Brno
  • University of Veterinary and Pharmaceutical Sciences Brno
  • Institute of Physics of Materials, Academy of Sciences of the Czech Republic
  • Veterinary Research Institute

Management of the Centre

International Management

The system of management and internal setting of CEITEC has been inspired and set according to most significant scientific institutions, top management is covered by foreign experts in science; the internal language is English. It is based on a regular evaluation of the quality of scientific results carried out by an independent team of top world experts in the given fields. An independent evaluation according to strict international standards is ensured by the Coordination Board and the International Scientific Advisory Board, whose members are significant people in foreign and Czech science.

• 
• Coordiantion Board
• Executive Director
• International Scientific Advisory Board
• Operational Director
• Scientific Director
• Commercial Director
• Coordinator of RP 1
• Coordinator of RP 7
• Research Group 1
• Research Group 1
• Research Group 1
• Research Group 1

Coordination Board

The highest authority of the Centre has been operational since December 2009. From the end of 2010 it meets on a quarterly basis (March, June, September, and December). The Board approves the Governing Documents (including among others the budget of the Central Management Structure), Common Rules and Policies and makes other key decisions, such as the approval of nominations for the Executive and Scientific Director. Coordination board is composed of representatives of project partners and external representatives.

Nominated Members – statutory representatives:

1. doc. PhDr. Mikuláš Bek, Ph.D., rector, Masaryk University
2. Prof. Ing. Karel Rais, CSc., MBA, rector, Brno University of Technology
3. Prof. Ing. Jaroslav Hlušek, CSc., rector, Mendel University in Brno
4. Prof. MVDr. Vladimír Večerek, CSc., MBA, rector, University of Veterinary and Pharmaceutical Sciences Brno
5. doc. RNDr. Petr Lukáš, CSc., dr. h. c., director, Institute of Physics of Materials
6. Prof. MVDr. Miroslav Toman, CSc., director, Veterinary Research Institute

Expert Representatives:

1. Prof. Gustaaf Borghs, IMEC Fellow, Full professor at Katholieke Universiteit Leuven, Belgium
2. Prof. Stefan Maier, Co-Director of Centre for Plasmonics & Metamaterials, Imperial College London, United Kingdom
3. Ing. Jaroslav Doležal, CSc., National Executive, Honeywell, Czech Republic
4. Prof. RNDr. Vladimír Král, DSc., API Development Director, Zentiva, Prague, Czech Republic

Guests: Governor of SM, Mayor of Brno, JIC Director

International Scientific Advisory Board (ISAB)

The highest scientific advisory body of the Centre that meets twice a year, at least once physically in Brno. The Board plays a crucial role in the Common Evaluation of Scientific Excellence as it sets the criteria, comments on the planned research activities and gives recommendations regarding strategic positioning of the Centre.

ISAB Members:

1. Prof. Andrés Aguilera, Head of Molecular Biology Dept., and Vice-Scientific Director, Andalusian Centre for Molecular Biology and Regenerative Medicine
2. Prof. Dirk Inzé, Scientific Director and Department Director, VIB Department of Plant Systems Biology, University of Gent, Belgium
3. Prof. Wolfgang Knoll, Scientific Director of AIT – Austrian Institute of Technology, Vienna, Austria
4. Prof. Yoshio Nishi, Director of Research of Centre for Integrated Systems, Stanford University, USA
5. Prof. Hartmut Oschkinat, Scientific Director, Leibnitz Institute for Molecular Pharmacology, Berlin, Germany